Taiwan Liposome Company, Ltd. American Depository Shares
TLC
TLC was delisted on the 28th of September, 2021.
7 hedge funds and large institutions have $5.46M invested in Taiwan Liposome Company, Ltd. American Depository Shares in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.
44% more capital invested
Capital invested by funds: $3.81M → $5.46M (+$1.66M)
40% more funds holding
Funds holding: 5 → 7 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.59M |
| 2 |
HR
Howe & Rusling
Rochester,
New York
|
+$3.08K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
+$1.23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$66.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$20.4K |
TLC Hedge Fund Activity: Q1 2019 in Review
7 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Taiwan Liposome Company, Ltd. American Depository Shares (TLC) for Q1 2019, worth a combined $5.46M — up 44% from $3.81M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TLC positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.59M. The largest seller was Millennium Management, cutting an estimated $66.5K.
- 7 institutional investors held Taiwan Liposome Company, Ltd. American Depository Shares (TLC) as of Q1 2019, up from 5 in Q4 2018.
- Funds reported $5.46M of Taiwan Liposome Company, Ltd. American Depository Shares stock for Q1 2019, up 44% quarter-over-quarter.
- 2 funds opened new Taiwan Liposome Company, Ltd. American Depository Shares positions in Q1 2019 and 0 closed out, a net change of +2 holders.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares buyer in Q1 2019 was Morgan Stanley, an estimated $1.59M added.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares seller in Q1 2019 was Millennium Management, an estimated $66.5K sold.
Based on aggregated 13F filings for Q1 2019.